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Background: The Swedish Cancer Register (SCR) is characterized by excellent quality and 
completeness overall, but the quality of the reporting may vary according to tumor site and age, 
and may change over time. The aim of the current study was to investigate the completeness of 
the reporting of central nervous system (CNS) tumor cases to the SCR.
Materials and methods: Individuals hospitalized for a CNS tumor between 1990 and 2014 
were identified using the Inpatient Register; the proportion of identified cases that did not have 
any cancer diagnosis reported to the SCR was subsequently assessed.
Results: Between 1990 and 2014, 58,698 individuals were hospitalized for a CNS tumor, and 
a large proportion of them did not have any cancer diagnosis reported to the SCR (26%). This 
discrepancy was particularly pronounced for benign tumors and among elderly patients (over 
30%). It was substantially lower for malignant brain tumors among adults (10%); moreover, 
no increase in the discrepancy between the two registers was observed in this group during the 
study period. Similar findings were found when assessing the concordance between the Cause 
of Death Register and the SCR. Among CNS tumor patients who were not reported to the SCR, 
a large proportion had only one hospital discharge diagnosis containing a CNS tumor (35%) and 
were less likely to be found in the Outpatient Register, which indicates that a large proportion 
of patients may have received an erroneous diagnosis.
Conclusion: While a large proportion of CNS tumor patients were not reported to the SCR, 
the discrepancy between the SCR and the Inpatient Register was relatively small for malignant 
brain tumors among adults and has remained stable throughout the study period. We do not 
recommend that data from the Inpatient Register are combined with the SCR to estimate CNS 
tumor incidence, without proper confirmation of the diagnoses, as a considerable proportion of 
CNS tumor diagnoses registered in the Inpatient Register is unlikely to reflect true CNS tumors.
Keywords: brain neoplasms, central nervous system neoplasms, registries, Sweden
Introduction
The Swedish Cancer Register (SCR) is an extremely valuable source of information for 
conducting epidemiological research. The SCR was established in 1958 and contains 
information about all malignant tumors and certain benign tumors (such as benign 
brain tumors), diagnosed in Sweden. According to Swedish act and government ordi-
nance, reporting of newly diagnosed primary cancer cases to the SCR is statutory for 
all healthcare providers.
Overall, the SCR has an excellent quality and completeness: a validation study 
estimated that, in 1998, ~96% of the newly diagnosed cancer cases were reported to 
the SCR.1 However, the study also reported that the quality of the reporting was site 
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and age specific. While the completeness was high for breast, 
female genital organs, and urologic sites, considerable under-
reporting was observed for leukemia, lymphoma, soft tissue, 
and nervous system tumors. Moreover, the underreporting 
was more elevated among elderly patients and for diagnoses 
that were not histologically confirmed.1
Two recent studies have investigated the underreporting 
of pancreatic cancer to the SCR: both the studies reported 
that pancreatic cancer cases were largely underreported.2,3 
Moreover, a recent Swedish study has shown that ~40% of 
liver cancer patients was not reported to the SCR.4 Findings 
from these studies indicate that for certain cancer diagnoses 
there could be substantial underreporting, especially if these 
cancers are associated with relatively short survival, as it 
is for pancreatic and liver cancer and tumors of the central 
nervous system (CNS).
The incidence of CNS tumors in Sweden has been stable 
during the last 40 years, but with some differences between 
tumor subtypes and age groups.5,6 Incidence trend studies 
describe potential changes in the occurrence of specific tumors 
over time, and although population exposure is at an ecologi-
cal level, they have been useful, for example, in checking the 
plausibility of reported increased risks of glioma associated 
with mobile phone use.6–11 However, such analyses rely on the 
complete reporting of tumor occurrences to the cancer regis-
ters; if completeness of reporting changes over time, spurious 
changes of the incidence may be observed, or an increase in 
incidence may go undetected. According to Kilander et al the 
observed declining incidence trends of pancreatic cancer12–14 
could be caused by changes in the underreporting to the can-
cer registers.3 Moreover, if the underreporting of CNS tumor 
diagnoses to the SCR is substantial, it may affect the statistical 
power of epidemiological studies on CNS tumor etiology and 
may introduce selection bias in studies relying solely on cancer 
register information for identification of cases. Therefore, it 
is of extreme importance, for both incidence trend and etio-
logical studies, to evaluate the completeness of CNS tumor 
reporting to the SCR.
Therefore, the aim of the current study was to assess the 
completeness of the reporting of CNS tumors to the Swedish 
Cancer Register by estimating the concordance of the SCR 
with the Inpatient Register between 1990 and 2014.
Methods
Identification of CNS tumor patients
We identified all hospital discharges that included a CNS 
tumor diagnosis, using the Swedish Inpatient Register.15 
Reporting of hospital discharge diagnoses to the Inpatient 
Register is mandatory for all publicly and privately funded 
healthcare providers. The Inpatient Register became nation-
wide in 1987, and the coverage is ~99%. The accuracy for 
most of the diagnostic codes varies between 85% and 95%.15 
All first occurrences of a CNS tumor diagnosis in the Inpa-
tient Register between 1987 and 2014 were extracted and, to 
exclude prevalent CNS tumor cases, individuals who had a 
diagnosis between 1987 and 1989 were excluded. CNS tumor 
patients were first divided into brain tumors and other CNS 
tumors and were then further classified according to tumor 
behavior (malignant, benign, and unknown). Since the Inpa-
tient Register does not contain information on morphology, it 
was not possible to investigate more specific tumor subtypes.
The SCR was used to identify all CNS tumor diagnoses 
that were reported between 1990 and 2015 and to collect 
information about all other cancer diagnoses for the patients 
hospitalized with a CNS tumor diagnosis. Some of the CNS 
tumors identified in the Inpatient Register are likely to be 
metastases from other primary tumors and should not be 
reported to the SCR. Therefore, we defined CNS tumor 
patients identified in the Inpatient Register as “not found in 
the SCR” if they did not have any cancer diagnosis in the 
SCR at any point in time (ie, between 1958 and 2015): this 
discrepancy between the two registers is the main focus of the 
study. In a secondary analysis, the Swedish Cause of Death 
Register was used to identify individuals who had a CNS 
tumor as main or contributing cause of death.16 The ninth and 
tenth revisions of the ICD were used to identify individuals 
with a CNS tumor diagnosis in the Inpatient and Cause of 
Death Registers during the study period. Brain tumors were 
defined as ICD10 codes C71, D33.0–D33.2, D43.0–D43.2, 
while other CNS tumors were defined as ICD10 codes C70, 
C72, D32, D33.3–D33.9, D42, D43.3–D43.9. In this study, 
tumors of the pineal and pituitary glands and craniopha-
ryngeal duct were not regarded as CNS tumors, although in 
some instances, such as in NORDCAN, they are considered 
as CNS tumors.17 Corresponding codes for the time period 
covered by ICD9 were used (see Table S1 for exact defini-
tion). The unique personal identity number provided to all 
Swedish residents have been used to link data from the three 
registers. The study was approved by the Regional Ethical 
Review Board in Stockholm (2011/634-31/4).
statistical analysis
As the main analysis, the discrepancy between the Inpatient 
Register and the SCR was evaluated (divided into brain 
tumors and other CNS tumors) according to tumor behavior 
(malignant, benign, and unknown), period of hospitalization 
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(1990–1999, 2000–2009, and 2010–2014), and whether the 
CNS tumor was the main or a secondary diagnosis in the 
Inpatient Register. Moreover, we further evaluated this dis-
crepancy among patients who had a cranial surgery.
In order to estimate the proportion of patients who 
may have had an erroneous CNS tumor diagnosis in the 
Inpatient Register, sensitivity analyses were performed in 
which the discrepancy between the two registers was evalu-
ated according to number of hospitalizations and type of 
clinic in which the patients had been hospitalized. We also 
checked whether CNS tumor cases that were not reported 
to the SCR had a CNS tumor diagnosis in the Outpatient 
Register: this analysis was performed only for patients who 
survived at least 1 year (to avoid including patients unlikely 
to be treated in outpatient care because of the severity of 
their disease, which could have prevented discharge from 
hospital care and is associated with short cancer survival), 
and were diagnosed from 2001 onward, the year in which 
the Outpatient Register was established. Individuals who 
migrated from or immigrated to Sweden before the date of 
the CNS tumor diagnosis in the Inpatient Register, and did 
not have any cancer diagnosis in the SCR, were excluded 
from the analysis: this was done to remove individuals who 
might have had the cancer diagnosis abroad and were hospi-
talized and treated in Sweden for a prevalent cancer. In order 
to determine whether the reporting to the SCR was related 
with short-term survival and, consequently, tumor severity, 
Cox regression models were used to compare the survival 
of CNS tumor patients reported to the SCR compared to 
those who were not reported. In the Cox regression models, 
age was used as the underlying time scale, and analyses 
were adjusted for year of hospitalization and location of the 
CNS tumor (brain tumor/other CNS tumor): analyses were 
stratified by tumor behavior and age at first hospitalization 
(age <70 years; age ≥70 years). All statistical analyses were 
performed using Stata 14.2 (StataCorp LP, College Station, 
TX, USA).
Results
Between 1990 and 2014, 58,698 individuals had been hos-
pitalized with a CNS tumor diagnosis: 50% of them had a 
CNS tumor diagnosis reported to the SCR during the same 
time period (n=29 335), while 26% of them did not have any 
cancer diagnosis reported to the SCR at any point in time 
(n=15,100). Among the 14,263 CNS tumor patients who did 
not have a CNS tumor in the SCR but had instead another 
cancer diagnosis reported to the SCR, the most common 
diagnoses were lung cancer (13%), breast cancer (11%), 
and prostate cancer (7%). There were more than 30,000 
patients who had a CNS tumor diagnosis reported to the SCR 
(n=30,728) and more than 95% of them were found also in 
the Inpatient Register (n=29,335).
The discrepancy between the two registers was lower for 
brain tumors (22%), compared to other CNS tumors (31%), 
and it was particularly elevated for benign tumors (Table 
1). Sensitivity analyses that took into account the number 
of hospital discharges containing a CNS tumor diagnosis 
showed that the discrepancies decreased with the number 
of hospitalizations (Table S2). Moreover, a high propor-
tion of patients had been hospitalized only once for a CNS 
tumor (35%). The types of clinics in which hospitalized 
patients got a CNS tumor diagnosis were mainly internal 
medicine, neurosurgery, and neurology clinics (44%, 34%, 
and 16% respectively) (not shown). The proportion of CNS 
tumor patients identified in the Inpatient Register that was 
not found in the SCR was lower if the CNS tumor patient 
was treated at a neurosurgery clinic (15%) compared to the 
other two clinics (22% for neurology and 27% for internal 
medicine).
CNS tumor patients who had the CNS tumor as the main 
diagnosis in the Inpatient register were more likely to have a 
cancer diagnosis in the SCR compared to patients who had 
the CNS tumor as a secondary diagnosis (Table 2). More-
over, brain tumor patients who had a cranial surgery were 
substantially more likely to be found in the SCR: only 3% 
of patients with a malignant brain tumor who had a cranial 
surgery did not have any cancer diagnosis reported to the 
SCR, while over a third of the patients who did not have a 
cranial surgery were not found in the SCR (Table 2).
Analysis stratified by age at CNS tumor 
diagnosis
The discrepancy between the Inpatient Register and the SCR 
differed according to age at diagnosis (Table 1). CNS tumor 
patients who did not have any cancer diagnosis reported to 
the SCR were older than those reported: the age difference 
was particularly pronounced for those with a malignant 
CNS tumor. While only a small proportion of children with 
a malignant CNS tumor had no cancer diagnosis in the SCR 
(~10%), this proportion was substantially higher among 
elderly individuals (Table 1). For benign tumors and tumors 
with unknown behavior, the discrepancy between the two 
registers was particularly elevated also among children and 
adolescents (Table 1).
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
17
8.
2 
on
 1
6-
Ju
l-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2019:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
84
Tettamanti et al
Table 1 Total number and proportions of central nervous system tumor cases in the inpatient register not found in the swedish 
Cancer Register by age at first hospitalization between 1990–2014
Brain tumors
Age at 
hospitalization 
(years)
All combined Malignant Benign Unknown behavior
Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total
0–19 491 (20.3) 2,414 120 (9.0) 1,329 121 (34.9) 347 251 (33.3) 754
20–69 2,994 (15.3) 19,630 910 (9.6) 9,486 691 (34.3) 2,014 1,399 (17.0) 8,237
70+ 4,214 (33.6) 12,565 2,165 (32.7) 6,629 286 (40.5) 706 1,784 (33.8) 5,286
Overall 7,699 (22.2) 34,612 3,195 (18.3) 17,444 1,098 (35.8) 3,067 3,434 (24.0) 14,277
Mean age at 
hospitalization
64.0 59.0 70.0 59.5 50.4 50.6 62.7 60.2
Other central nervous system tumors (excluding brain tumors)
0–19 199 (35.7) 557 17 (10.1) 169 122 (52.1) 234 60 (38.0) 158
20–69 3,259 (22.9) 14,206 110 (9.7) 1,134 2,637 (23.5) 11,230 512 (27.7) 1,850
70+ 3,943 (42.3) 9,323 208 (25.6) 813 3,310 (44.8) 7,394 430 (38.1) 1,130
Overall 7,401 (30.7) 24,086 335 (15.8) 2,116 6,069 (32.2) 18,858 1,002 (32.0) 3,138
Mean age at 
hospitalization
66.5 62.1 67.5 59.1 67.5 62.9 60.4 59.8
Table 2 Total number and proportions of central nervous system tumor cases in the inpatient register not found in the swedish 
Cancer register by diagnosis (main/secondary) and cranial surgery (yes/no) between 1990–2014
Brain tumors
 All combined Malignant Benign Unknown behavior
 Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total
Main diagnosis 5,950 (20.8) 28,619 2,717 (18.1) 14,993 719 (32.5) 2,211 2,534 (21.9) 11,552
secondary 
diagnosis
1,749 (29.2) 5,993 478 (19.5) 2,451 379 (44.3) 856 900 (33.0) 2,725
Cranial surgery 1,082 (7.1) 15,435 244 (3.0) 8,016 441 (24.6) 1,796 401 (7.0) 5,691
no cranial 
surgery
6,617 (34.5) 19,177 2,951 (31.3) 9,428 657 (51.7) 1,271 3,033 (35.3) 8,586
Other central nervous system tumors (excluding brain tumors)
Main diagnosis 3,787 (22.3) 16,998 204 (15.3) 1,330 2,902 (21.9) 13,284 685 (28.5) 2,406
secondary 
diagnosis
3,614 (51.0) 7,088 131 (16.7) 786 3,167 (56.8) 5,574 317 (43.3) 732
Cranial surgery 1,212 (12.4) 9,788 9 (2.8) 322 1,113 (12.7) 8,750 90 (12.5) 721
no cranial 
surgery
6,189 (43.3) 14,298 326 (18.2) 1,794 4,956 (49.0) 10,108 912 (37.7) 2,417
Analysis stratified by calendar period
As shown in Figure 1, the discrepancy between the Inpatient 
Register and the SCR for brain tumors increased slightly 
during the first years of the 1990s, remained rather constant 
between 1996 and 2009, after which it has decreased. In 
2014 the discrepancy was almost back at the level observed 
in 1990 (21% compared to 19%). However, for benign brain 
tumors, it increased during the second decade and remained 
at a high level until the end of the study period. For malignant 
brain tumors, as well as for those with unknown behavior, 
a decrease was observed since the beginning of the 2000s, 
particularly among individuals aged 20–69 years (Figure 
1; Table 3). Among elderly individuals diagnosed with a 
malignant brain tumor, a small increase in the discrepancy 
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between the two registers was observed in the second decade 
(+4%): however, after 2010 it decreased by 10% (Table 3). 
The discrepancy for malignant brain tumors among children 
and adolescents has constantly increased over time, by ~3% 
in each decade (Table 3). For other CNS tumors the propor-
tion of cases identified in the Inpatient Register that was not 
found in the SCR has increased from 25% in 1990 to 33% in 
2014: this increase was mainly driven by the discrepancies 
observed for benign tumor patients, particularly from 2004, 
which however leveled after 2008 (Figure 2).
survival analysis
Age-specific Cox regression analyses showed that elderly 
CNS tumor patients (age ≥70 years) diagnosed with a benign 
or malignant tumor, who had no cancer diagnosis in the SCR, 
had a worse survival compared to those reported; whereas 
Overall (n=34,589)
Year
2005 2010 2015200019951990
Pe
rc
en
t
10
20
30
40
50
Malignant (n=17,433)
Unknown (n=14,228)Benign (n=3,048)
Figure 1 Proportions of brain tumor cases in the inpatient register not found in the swedish Cancer register by tumor behavior between 1990–2014.
Overall (n=24,104)
Year
2005 2010 2015200019951990
10
0
20
30
40
50
Malignant (n=2,116)
Unknown (n=3,133)Benign (n=18,876)
Pe
rc
en
t
Figure 2 Proportions of other central nervous system tumor cases in the inpatient register not found in the swedish Cancer register by tumor behavior between 
1990–2014.
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among younger patients (age <70 years), those who were 
not found in the SCR had instead a better survival (Table 4).
Concordance between inpatient register 
and Outpatient register
When examining the concordance between the Inpatient 
and Outpatient Registers, we found that CNS tumor patients 
who did not have any cancer diagnosis reported to the SCR 
were also less likely to have a CNS tumor diagnosis in the 
Outpatient Register, compared to patients who were found in 
the SCR. For example, 36% of brain tumor cases not found 
in the SCR had no CNS tumor diagnosis in the Outpatient 
Register, while only 15% of the brain tumor cases found 
also in the SCR did not have a CNS tumor reported to the 
Outpatient Register. Similar findings were found in analysis 
stratified by age at diagnosis (Table S3).
Table 3 Proportions of central nervous system tumor cases in the inpatient register not found in the swedish Cancer register 
between 1990–2014 by age at first hospitalization and decade of diagnosis
Brain tumors
 All combined Malignant Benign Unknown behavior
Age at 
hospitalization 
(years)
Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total Not 
reported, 
n (%)
Total
Between 
1990–1999
0–19 162 (16.4) 989 39 (6.8) 578 34 (23.5) 145 89 (32.3) 276
20–69 1,067 (14.2) 7,536 417 (9.8) 4,262 172 (25.6) 672 481 (18.1) 2,661
70+ 1,619 (34.2) 4,730 893 (32.0) 2,794 97 (40.9) 237 639 (37.0) 1,727
Overall 2,848 (21.5) 13,255 1,349 (17.7) 7,634 303 (28.8) 1,054 1,209 (25.9) 4,664
Between 
2000–2009
0–19 211 (23.0) 919 47 (9.8) 482 67 (43.8) 153 98 (33.9) 289
20–69 1,287 (16.5) 7,798 370 (10.4) 3,557 344 (39.0) 882 576 (17.0) 3,383
70+ 1,874 (36.4) 5,145 956 (36.5) 2,662 119 (40.2) 296 809 (36.0) 2,249
Overall 3,372 (24.3) 13,862 1,373 (20.5) 6.701 530 (39.8) 1,331 1,483 (25.0) 5,921
Between 
2010–2014
0–19 118 (23.3) 506 34 (12.6) 269 20 (40.8) 49 64 (33.9) 189
20–69 640 (14.9) 4,296 123 (7.4) 1,667 175 (38.0) 460 342 (15.6) 2,193
70+ 721 (26.8) 2,690 316 (26.1) 1.213 70 (40.5) 173 336 (25.7) 1,310
Overall 1,479 (19.7) 7,492 473 (15.0) 3,149 265 (38.9) 682 742 (20.1) 3,692
Central nervous system tumors (excluding brain tumors)
Between 
1990–1999
0–19 87 (34.5) 252 9 (9.7) 92 63 (52.9) 119 15 (35.7) 42
20–69 909 (18.9) 4,805 49 (10.5) 465 740 (18.8) 3,922 120 (28.4) 422
70+ 1,114 (39.3) 2,838 86 (29.2) 295 925 (40.2) 2,303 104 (42.3) 246
Overall 2,110 (26.7) 7,895 144 (16.9) 852 1,728 (27.4) 6,344 239 (33.7) 710
Between 
2000–2009
0–19 71 (35.2) 202 7 (13.0) 54 32 (43.8) 73 32 (41.0) 78
20–69 1,386 (23.3) 5,955 39 (8.2) 474 1,112 (24.2) 4,599 235 (26.6) 884
70+ 1,720 (43.2) 3,979 99 (25.5) 389 1,386 (46.4) 2,987 239 (39.1) 611
Overall 3,177 (31.3) 10,136 145 (15.8) 917 2,530 (33.0) 7,659 763 (31.4) 2,428
Between  
2010–2014
0–19 41 (39.8) 103 1 (4.3) 23 27 (64.3) 42 13 (34.2) 38
20–69 964 (28.0) 3,446 22 (11.3) 195 785 (29.0) 2,709 157 (29.0) 542
70+ 1,109 (44.3) 2,506 23 (17.8) 129 999 (47.5) 2,104 87 (31.9) 273
Overall 2,114 (34.9) 6 055 46 (13.3) 347 1,811 (37.3) 4, 855 257 (30.1) 855
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Concordance between Cause of Death 
register and sCr
In a secondary analysis, we used the Cause of Death Register 
to identify individuals who had a CNS tumor as a main or 
contributing cause of death between 1990 and 2014 (n=19 
029). Overall, 28% of these individuals did not have any 
cancer diagnosis reported to the SCR at any point in time 
(n=5,311). However, less than 6% of individuals who had a 
CNS tumor as a cause of death did not have a cancer diag-
nosis in the SCR or a CNS tumor diagnosis in the Inpatient 
Register (n=1,116).
Discussion
In the current study we found that a large proportion of 
patients (26%) who had a CNS tumor diagnosis registered 
in the Inpatient Register did not have any cancer diagnosis 
reported to the SCR. The discrepancy between the Inpatient 
Register and the SCR was lower for brain tumors (22%) 
compared to other CNS tumors (31%) and was particularly 
pronounced for benign CNS tumors and among elderly 
patients, while among children and adults diagnosed with a 
malignant tumor, it was substantially smaller (~10%).
Our results are in agreement with the findings from a pre-
vious validation study of the SCR.1 Similarly to what we have 
reported, they found that a large proportion of elderly cancer 
patients was not reported to the SCR. However, the authors 
focused only on malignant tumors and evaluated the reporting 
to the SCR only in 1998: for these reasons, their estimated 
underreporting is lower than what we have reported.
Often CNS tumors are not primary tumors but metastases 
and should therefore not be reported to the SCR. For this 
reason, we assessed whether CNS tumor patients identified 
in the Inpatient Register had any cancer diagnosis reported 
to the SCR at any point in time, rather than only investigat-
ing whether they had a CNS tumor reported to the SCR. We 
found that approximately half of the CNS tumor patients 
did not have a CNS tumor diagnosis in the SCR, while 26% 
did not have any cancer diagnosis reported to the SCR. This 
difference between the two analyses is unlikely to have been 
caused entirely by metastatic cases; thus, it is possible that our 
findings have underestimated the true discrepancies between 
the Inpatient Register and the SCR. On the other hand, we 
found that patients with only one hospital discharge diagnosis 
with a CNS tumor recorded were less likely to be found in 
the SCR than patients who had several hospital discharges 
mentioning a CNS tumor. Moreover, a considerable number 
of cases not found in the SCR were treated at clinics that do 
not typically treat CNS tumors, quite many (30%) had only 
Table 4 Five-year and overall mortality after central nervous tumor diagnosis in the inpatient register according to the reporting to 
the Swedish Cancer Register between 1990–2014, stratified by tumor behavior and age at first hospitalization
 
 
Age <70 years Age ≥70 years
N HR (95% CI) N HR (95% CI)
5-year survival
Cns tumors with unknown grading     
inpatient register only 2,216 0.35 (0.32–0.38) 2,195 0.86 (0.81–0.91)
inpatient and Cancer register 10,891 1 (ref) 6,368 1 (ref)
Benign Cns tumors     
inpatient register only 3,570 0.98 (0.85–1.14) 3,589 1.16 (1.08–1.24)
inpatient and Cancer register 13 800 1 (ref) 8,079 1 (ref)
Malignant Cns tumors     
inpatient register only 1,157 0.73 (0.68–0.79) 2,373 1.18 (1.12–1.25)
inpatient and Cancer register 12,118 1 (ref) 7,442 1 (ref)
Overall survival
Cns tumors with unknown grading     
inpatient register only 2,216 0.34 (0.32–0.37) 2, 195 0.97 (0.92–1.03)
inpatient and Cancer register 10,891 1 (ref) 6,368 1 (ref)
Benign Cns tumors     
inpatient register only 3,570 0.90 (0.81–0.99) 3,589 1.26 (1.20–1.33)
inpatient and Cancer register 13,800 1 (ref) 8,079 1 (ref)
Malignant Cns tumors
inpatient register only 1,157 0.63 (0.58–0.68) 2,373 1.35 (1.28–1.41)
inpatient and Cancer register 12,118 1 (ref) 7,442 1 (ref)
Notes: Analyses adjusted for year of hospitalization, and brain tumor diagnosis. Age was used as the underlying time scale.
Abbreviation: Cns, central nervous system.
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
17
8.
2 
on
 1
6-
Ju
l-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2019:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
88
Tettamanti et al
one hospital discharge diagnosis with a CNS tumor recorded, 
and a large proportion of patients not found in the SCR did 
not have a CNS tumor diagnosis in the Outpatient Register. 
In the latter analysis we excluded patients who died within 
1 year of diagnosis to avoid including patients who might 
not have survived long enough to seek outpatient care, and 
we restricted the analyses to the years when the Outpatient 
Register was available (from 2001). All these findings indi-
cate that the CNS tumor diagnosis in the Inpatient Register 
may have been incorrect in many instances. The previously 
mentioned validation study of the SCR reviewed a sample 
of medical records for unreported cancer cases and found 
that for around 20% of the records, the patients did not have 
a cancer.1
As already pointed out by Barlow et al, there is a mis-
understanding among clinicians who believe that tumor 
cases should be reported to the SCR only if the diagnosis is 
histologically or cytologically confirmed.1 Cox regression 
analyses indicated that elderly patients diagnosed with a 
benign or malignant CNS tumor who were not found in the 
SCR had a worse survival. This suggests that the patient’s 
prognosis could have had an impact on the clinician’s deci-
sion to perform a histological confirmation of the tumor. 
Therefore, individuals with a worse prognosis (because of 
tumor severity, advanced age, or presence of other comor-
bidities) were probably less likely to receive a histological 
confirmation, as a severely ill patient might not benefit from 
the procedure necessary to have the tumor histologically 
confirmed, and hence less likely to be reported to the SCR. 
This could explain the high proportion of elderly patients 
identified in the Inpatient Register that were not found in 
the SCR, almost 50% for other benign CNS tumors and over 
30% for malignant brain tumors.
Also among children and adolescents we found a large 
discrepancy between the SCR and the Inpatient Register for 
benign CNS tumors. However, when assessing the concor-
dance between the Inpatient and the Outpatient Registers, we 
found that 20% of the CNS tumor patients in this age group 
that were not found in the SCR did not have a CNS tumor 
diagnosis in the Outpatient Register; this proportion was sub-
stantially smaller (4%) if the patient had a cancer diagnosis 
in the SCR. This indicates that some children may have had 
an erroneous diagnosis reported to the Inpatient Register.
When evaluating the discrepancies between the Cause of 
Death Register and the SCR, we found that the proportion of 
CNS tumor patients not found in the SCR (28%) was similar 
to the one observed in the analysis of the Inpatient Register 
(26%). An explanation for the similar findings is that often 
the physician who compiles the death certificate may look 
at the previous medical history in the medical records. In 
fact, ~94% of individuals who had a CNS tumor as main or 
contributing cause of death had a CNS tumor diagnosis in 
the Inpatient Register.
A major strength of the current study is that the data 
were derived from high-quality national registers and that we 
were able to evaluate the discrepancies between the Inpatient 
Register and the SCR by age at diagnosis, tumor behavior 
(malignant, benign, unknown), type of diagnosis (main or 
secondary), and by cranial surgery. Moreover, since we 
had data for a relatively long period of time (from 1990 to 
2014), we had the opportunity to analyze the trends of these 
discrepancies over time. Another strength of this study was 
that we were able to remove individuals who emigrated or 
immigrated before they were hospitalized for a CNS tumor, 
in order to exclude CNS tumor patients diagnosed in another 
country who then moved to Sweden to receive treatment: 
only newly detected cancers should be reported to the SCR, 
cancers diagnosed in other countries should not be reported.
A limitation of this study is that diagnoses in the Inpa-
tient Register have an accuracy that ranges between 85% 
and 95%.15 We found that CNS tumor patients, aged ≤69 
years, who were not found in the SCR, had a better survival 
compared to those who had a cancer diagnosis reported to 
the SCR; this suggests that some CNS tumor patients identi-
fied through the Inpatient Register did not actually have a 
CNS tumor, leading to an overestimation of the discrepan-
cies between the two registers. This is also supported by the 
fact that the proportion of cases not found in the SCR varies 
depending on the type of clinic that made the diagnosis, sug-
gesting that the CNS tumor diagnosis reported in the Inpatient 
Register may be less accurate in clinics that do not primarily 
treat such tumors. These diagnoses could have suspected 
tumors that were registered in the Inpatient Register but were 
not later confirmed. Moreover, not all CNS tumor patients 
who had a cranial surgery were reported to the SCR, which 
clearly indicates that some CNS tumors diagnoses were not 
histologically confirmed after the surgery.
The fact that not all CNS tumors are reported to the 
SCR does not necessarily have an effect on the validity of 
etiological studies, but it may affect the statistical power, 
introduce selection bias if the exposure of interest is related 
with the reasons that led to the underreporting to the SCR, 
and overestimate survival if CNS tumor cases with a worse 
prognosis are less likely to be reported. Moreover, the sus-
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pected underreporting of CNS tumors could have had an 
impact on the incidence trends, as it has been suggested 
for pancreatic cancer.3 Since the discrepancies between the 
Inpatient Register and the SCR for malignant brain tumors 
were rather stable during the study period, particularly 
among individuals aged 20–69 years, the incidence trends 
for malignant brain tumors are likely not affected by spurious 
changes introduced by changes in the underreporting to the 
SCR, with the exception of the incidence in the oldest age 
group (≥70 years) which may appear to have increased as a 
result of better reporting to the SCR. Regarding benign CNS 
tumors, the discrepancy between the registers has markedly 
increased from 2004 and has then leveled off after 2008. 
The increased proportion of benign CNS tumors that were 
not found in the SCR could have hidden a real increase in 
the incidence of these tumors, but could also be due to an 
increased detection of smaller asymptomatic benign tumors 
through the higher access to MRI scanning, tumors that would 
previously have gone unnoticed.
We observed large discrepancies between the Inpatient 
Register and the SCR, particularly for benign tumors and 
for elderly patients. Although, as we have shown, it is pos-
sible that some diagnoses in the Inpatient Register may not 
have been accurate, parts of the discrepancies are probably 
due to a true underreporting of CNS tumor cases to the 
SCR. Other studies have also indicated that benign CNS 
tumors might be underreported, for example, a study on 
incidence trends of intracranial meningiomas in the Nordic 
countries.5 A Finnish study of 42 meningioma cases showed 
that approximately a third of the cases was not reported to 
the Finnish Cancer Register.18 Moreover, a US study found 
an increasing incidence of benign and borderline brain 
tumors that was related with the increased reporting of non-
histologically confirmed cases, suggesting that these cases 
were previously underreported.19
The fact that there could be different procedures regard-
ing cancer registration in different countries, and over time, 
should be kept in mind when comparing incidence trends 
or cancer registration completeness across countries. For 
example, the Danish Cancer Register has since 2004 adopted 
new electronic reporting procedures that integrate reporting 
to the Cancer Register with reporting to the National Patient 
Register. Should a tumor reported to the Patient Register, 
pathology register, or Cause of Death Register despite this 
not be found in the Cancer Register, reminders are sent to 
the hospitals and the physicians who failed to report the new 
cancer case.20 After the introduction of these new procedures, 
an apparent increase in the incidence of CNS tumors was 
observed in Denmark, while more stable trends were found 
in the other Nordic countries:17 this was probably due to a 
decreased underreporting of CNS tumors in Denmark after 
2004. Such procedures would be worthwhile to consider 
also in Sweden, to minimize underreporting of benign and 
inoperable tumors to the SCR.
Conclusion
In this study we found that a large proportion of patients 
registered with a CNS tumor diagnosis in the Inpatient 
Register did not have any cancer diagnosis reported to the 
SCR. The discrepancy between the registers was in some 
instances substantial, especially among elderly patients 
and for benign tumors, while for malignant CNS tumors in 
patients below 70 years it was smaller and did not change 
over time. As high levels of underreporting to the SCR 
have been found also for pancreatic and liver cancer, it is 
important to remind clinicians to report cancer cases to the 
SCR also when histological confirmation is not available, if 
the tumors can be unequivocally diagnosed through other 
means, such as imaging. However, we do not recommend 
that data from the Inpatient Register is combined with the 
SCR to estimate CNS tumor incidence, without proper 
confirmation of the diagnoses, as a considerable propor-
tion of CNS tumor diagnoses registered in the Inpatient 
Register is unlikely to reflect true CNS tumors. Results 
from our study should be taken into consideration when 
performing etiological and incidence trend studies on CNS 
tumors using the SCR.
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Supplementary materials
Table S1 list of iCD codes used to identify central nervous system tumor patients in the inpatient register and Cause of Death 
register
Brain tumors ICD-9 ICD-10
Malignant 191 C71
Benign 225a D33.0–D33.2
Unknown grading 237F D43.0–D43.2
Other CNS tumors
Malignant 192 C70; C72
Benign 225B; 225C; 225E D32; D33.3–D33.9; D42
Unknown grading 237g; 237X D42; D43.3–D43.9
Table S2 Total number and proportions of patients with a central nervous system tumor diagnosis in the inpatient register not found 
in the swedish Cancer register between 1990–2014, by number of hospital discharge diagnosis containing a central nervous system 
tumor diagnosis
Number of hospital discharge diagnosis (%)
At least one At least two At least three At least four
Brain tumors n=34,612 n=23,842 n=17,944 n=13,445
all combined 22.2 15.9 11.5 8.5
Malignant 18.3 13.6 9.5 7.1
Benign 35.8 26.8 21.4 16.9
Unknown behavior 24.0 16.7 12.5 9.2
Other CNS tumors n=24,086 n=13,996 n=8,332 n=4,906
all combined 30.7 21.5 18.3 17.4
Malignant 15.8 14.3 11.4 11.2
Benign 32.2 22.0 18.8 18.2
Unknown behavior 31.9 22.6 19.3 17.2
Abbreviation: Cns, central nervous system.
Table S3 Total number and proportion of central nervous system tumor cases in the inpatient register not found in the Outpatient 
register with a central nervous system tumor diagnosis between 2001–2014
 
 
Brain tumors Other CNS tumors
Not found in 
OutpR (%)
Total Not found in 
OutpR (%)
Total
all ages
not reported sCr 804 (35.6) 2,255 1,634 (38.6) 4,233
reported sCr 1,242 (15.4) 8,079 1,492 (17.1) 8,721
age 0–19 years
not reported sCr 58 (19.8) 293 31 (31.0) 100
reported sCr 41 (4.4) 891 20 (11.9) 168
age 20–69 years
not reported sCr 466 (32.9) 1,418 555 (25.7) 2,160
reported sCr 766 (13.0) 5,873 644 (10.7) 6,011
age 70+ years
not reported sCr 280 (51.5) 544 1,048 (53.1) 1,973
reported sCr 435 (34.1) 1,274 828 (32.6) 2,542
Notes: Only patients surviving at least one year have been included in this analysis.
Abbreviations: Cns, central nervous system; sCr, swedish Cancer register; Outpr, Outpatient register.
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